Association between lipid-lowering agents with intervertebral disc degeneration, sciatica and low back pain: a drug-targeted mendelian randomized study and cross-sectional observation

The results of cross-sectional study suggested that non-use of statins was positively correlated with LBP. The results of Mendelian randomization study suggest that NPC1L1 could lower the risk of developing IVDD by reducing TC, LDL-C, and non-HDL-C levels. Additionally, PCSK9 may reduce the risk of developing sciatica by lowering LDL-C and TC levels. In contrast, HMGCR appears to have no significant effect on IVDD, sciatica, or LBP development. Nonetheless, further research is needed to verify these preliminary results. MST1 warrants further exploration as a potential therapeutic target. It is necessary to do further research to validate these findings.

Authors

Institutions

Publication Details

Journal
Lipids in Health and Disease
Published
2024-10-02
DOI
https://doi.org/10.1186/s12944-024-02311-w
Citations
4
Primary Topic
Musculoskeletal pain and rehabilitation
Type
article
Field-Weighted Citation Impact
1.79

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association between lipid-lowering agents with intervertebral disc degeneration, sciatica and low back pain: a drug-targeted mendelian randomized study and cross-sectional observation

Xinqiao Chu, Shuo Feng, Yufang Zhang, Qiubai Jin et al.
4 citations
Lipids in Health and Disease
Musculoskeletal pain and rehabilitation
1.79
article

Association between lipid-lowering agents with intervertebral disc degeneration, sciatica and low back pain: a drug-targeted mendelian randomized study and cross-sectional observation

Xinqiao Chu, Shuo Feng, Yufang Zhang, Qiubai Jin, Ji Zheng, Yaning Biao, Yixin Zhang, Chenxu Liu, Ya Gao
article en
4 citations

Abstract

The results of cross-sectional study suggested that non-use of statins was positively correlated with LBP. The results of Mendelian randomization study suggest that NPC1L1 could lower the risk of developing IVDD by reducing TC, LDL-C, and non-HDL-C levels. Additionally, PCSK9 may reduce the risk of developing sciatica by lowering LDL-C and TC levels. In contrast, HMGCR appears to have no significant effect on IVDD, sciatica, or LBP development. Nonetheless, further research is needed to verify these preliminary results. MST1 warrants further exploration as a potential therapeutic target. It is necessary to do further research to validate these findings.

Lipids in Health and DiseaseVol. 23(1)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Hebei University of Chinese Medicine (CN), Guang’anmen Hospital (CN)
National Natural Science Foundation of China, Natural Science Foundation of Hebei Province, China Academy of Chinese Medical Sciences
Good health and well-being
Openalex Percentile: Top 15%
Musculoskeletal pain and rehabilitation
1.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Association between lipid-lowering agents with intervertebral disc degeneration, sciatica and low back pain: a drug-targeted mendelian randomized study and cross-sectional observation — Xinqiao Chu, Shuo Feng, et al. · Lipids in Health and Disease (2024) | TGRS Research Map | TGRS